Cellular Dynamics to Present at Leerink Swann Global Healthcare Conference
06 févr. 2014 16h30 HE
|
Cellular Dynamics International, Inc.
MADISON, Wis., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the Leerink...
Cellular Dynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference
10 janv. 2014 08h00 HE
|
Cellular Dynamics International, Inc.
MADISON, Wis., Jan. 10, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the 32nd...
Cellular Dynamics Signs Agreement With Nestle Institute of Health Sciences to Supply iCell(R) and MyCell(R) Products for Nutritional Research
08 janv. 2014 02h00 HE
|
Cellular Dynamics International, Inc.
MADISON, Wis., Jan. 8, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced signing a long-term supply agreement with the Nestlé Institute of Health...
The Hamner Institutes and Cellular Dynamics Collaborate to Develop In Vitro Assays Using Human iPS Cell-Derived Hepatocytes
09 déc. 2013 08h00 HE
|
Cellular Dynamics International, Inc.
RESEARCH TRIANGLE PARK, N.C. and MADISON, Wis., Dec. 9, 2013 (GLOBE NEWSWIRE) -- The Hamner Institutes for Health Sciences today announced a collaborative agreement with Cellular Dynamics...
Jain Foundation Signs Agreement With Cellular Dynamics to Create iPSC Lines From Patients With Muscular Dystrophies
04 déc. 2013 08h00 HE
|
Cellular Dynamics International, Inc.
SEATTLE and MADISON, Wis., Dec. 4, 2013 (GLOBE NEWSWIRE) -- The Jain Foundation, a non-profit organization whose mission is to cure muscular dystrophies caused by dysferlin protein deficiency, today...
Cellular Dynamics International Reports Third Quarter 2013 Financial Results
12 nov. 2013 16h05 HE
|
Cellular Dynamics International, Inc.
MADISON, Wis., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), a developer and manufacturer of fully functioning human cells in industrial quantities to...
Cellular Dynamics International Announces Conference Call to Discuss Third Quarter 2013 Financial and Operating Results
05 nov. 2013 08h00 HE
|
Cellular Dynamics International, Inc.
MADISON, Wis., Nov. 5, 2013 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced that it will report third quarter 2013 financial and operating results after the...
Cellular Dynamics Receives Formal Notice of Grant Award (NGA) for $16 Million Stem Cell Banking Project
04 nov. 2013 16h05 HE
|
Cellular Dynamics International, Inc.
MADISON, Wis., Nov. 4, 2013 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) announced today that the company has received the Notice of Grant Award (NGA) from the California...
Cellular Dynamics Issued U.S. Patent Covering Differentiation of iPS Cells Into Endothelial, Hematopoietic Cells
16 oct. 2013 08h00 HE
|
Cellular Dynamics International, Inc.
MADISON, Wis., Oct. 16, 2013 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL), announced today that the U.S. Patent and Trademark Office (PTO) issued Patent No. 8,557,580...
Cellular Dynamics Issued U.S. Patent Covering iPSC Episomal Reprogramming
02 oct. 2013 08h00 HE
|
Cellular Dynamics International, Inc.
MADISON, Wis., Oct. 2, 2013 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL), announced today that the U.S. Patent and Trademark Office (PTO) issued Patent No. 8,546,140...